| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of herb-drug interactions of mistletoe with the tamoxifen metabolite (E/Z)-endoxifen and cytochrome P450 3A4/5 and 2D6 in vitro
|
Weissenstein, Ulrike
|
|
2019
|
61 |
S1 |
p. 6
|
artikel
|
| 2 |
Annual dynamic of mass production of Viscum album L. on Malus domestica L.
|
Urech, Konrad
|
|
2019
|
61 |
S1 |
p. 6
|
artikel
|
| 3 |
A single-case series on the tolerability of targeted therapy and concomitant mistletoe therapy in the treatment of oncological patients
|
Flür, Martin
|
|
2019
|
61 |
S1 |
p. 9
|
artikel
|
| 4 |
Association between fatigue and laboratory parameters in a longitudinal randomized controlled mistletoe trial in breast cancer patients
|
Reif, Marcus
|
|
2019
|
61 |
S1 |
p. 2
|
artikel
|
| 5 |
A systematic review and meta-analysis on the survival of cancer patients treated with a fermented Viscum album L. extract (Iscador) – an update of findings
|
Ostermann, Thomas
|
|
2019
|
61 |
S1 |
p. 11-12
|
artikel
|
| 6 |
Author Index
|
|
|
2019
|
61 |
S1 |
p.
|
artikel
|
| 7 |
Body temperature in advanced pancreatic cancer patients receiving mistletoe extract versus no treatment. Results from a randomized clinical trial (ISRCTN70760582)
|
Tröger, Wilfried
|
|
2019
|
61 |
S1 |
p. 6
|
artikel
|
| 8 |
Cancer register based survival analysis in patients which were treated with integrative oncology – Concept and first results
|
Ostermann, Thomas
|
|
2019
|
61 |
S1 |
p. 2
|
artikel
|
| 9 |
Cancer-related fatigue and cancer-related insomnia in breast cancer patients – clinic, diagnosis and evidenced-based therapies – an overview
|
Kröz, Matthias
|
|
2019
|
61 |
S1 |
p. 2
|
artikel
|
| 10 |
Case report: Neoadjuvant treatment with mistletoe and chemotherapy in a patient with ovarian-cancer, peritoneal carcinosis and metastasis of the spleen
|
Sterner, Martin-Günther
|
|
2019
|
61 |
S1 |
p. 6
|
artikel
|
| 11 |
Case reports of Viscum album extract therapy in oncology
|
Werthmann, Paul Georg
|
|
2019
|
61 |
S1 |
p. 9-10
|
artikel
|
| 12 |
Checkpoint inhibitors: A starter
|
Dingermann, Theo
|
|
2019
|
61 |
S1 |
p. 2-3
|
artikel
|
| 13 |
Clinical safety of combined targeted and Viscum album L. therapy in oncological patients
|
Thronicke, Anja
|
|
2019
|
61 |
S1 |
p. 7-8
|
artikel
|
| 14 |
Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer
|
Thronicke, Anja
|
|
2019
|
61 |
S1 |
p. 7
|
artikel
|
| 15 |
Colloidal formulation of mistletoe extracts in a pharmaceutical flow process for targeted cancer therapy
|
Leneweit, Gero
|
|
2019
|
61 |
S1 |
p. 1
|
artikel
|
| 16 |
Composition of the leaf proteome in Viscum album
|
Schröder, Lucie
|
|
2019
|
61 |
S1 |
p. 5
|
artikel
|
| 17 |
Current developments of clinical research on mistletoe therapy in cancer care
|
Kienle, Gunver S.
|
|
2019
|
61 |
S1 |
p. 2
|
artikel
|
| 18 |
Does mistletoe interact with tumor immune-escape mechanisms?
|
Zimmermann-Klemd, Amy Marisa
|
|
2019
|
61 |
S1 |
p. 5
|
artikel
|
| 19 |
Editorial
|
Scheer, Rainer
|
|
2019
|
61 |
S1 |
p.
|
artikel
|
| 20 |
Editorial
|
Scheer, Rainer
|
|
2019
|
61 |
S1 |
p.
|
artikel
|
| 21 |
Editorial Board
|
|
|
2019
|
61 |
S1 |
p.
|
artikel
|
| 22 |
Effect of mistletoe preparations on cell migration: Exploration of 3D experimental models
|
Dolder, Alexandra
|
|
2019
|
61 |
S1 |
p. 5-6
|
artikel
|
| 23 |
Financial burden of all-stage lung and breast cancer patients as an early indicator for emotional and physical burden
|
Thronicke, Anja
|
|
2019
|
61 |
S1 |
p. 8-9
|
artikel
|
| 24 |
First prospective study of a combined immune therapy of checkpoint inhibitors ± CTX plus Viscum album L. in non-small cell lung cancer (NSCLC) in UICC stage III B-IV B
|
Grah, Christian
|
|
2019
|
61 |
S1 |
p. 6-7
|
artikel
|
| 25 |
Impact of Viscum album treatments on the thermo-coherence of non-metastasized breast cancer patients
|
Oei, Shiao Li
|
|
2019
|
61 |
S1 |
p. 4-5
|
artikel
|
| 26 |
Influence of a HelixorⓇ P infusion therapy on the Cancer-related Fatigue (CrF) of patients with advanced breast cancer or NSCLC during oncological standard therapy
|
Jaenichen, Doreen
|
|
2019
|
61 |
S1 |
p. 1-2
|
artikel
|
| 27 |
Influence of mistletoe preparations on check-point ligands on tumor cells in vitro
|
Devi, Seema
|
|
2019
|
61 |
S1 |
p. 3
|
artikel
|
| 28 |
Interaction of aqueous mistletoe (Viscum album) extracts with other oncological treatments: A systematic literature review
|
Lemche, Alexandra
|
|
2019
|
61 |
S1 |
p. 2-3
|
artikel
|
| 29 |
Intratumoral, intrapleural and intraperitoneal mistletoe therapy: Effects and adverse reactions
|
Wiebelitz, Karl Rüdiger
|
|
2019
|
61 |
S1 |
p. 9
|
artikel
|
| 30 |
Intravenous application of mistletoe extract: Review of the reported data and outline of a planned study with Iscador
|
Bar-Sela, Gil
|
|
2019
|
61 |
S1 |
p. 10
|
artikel
|
| 31 |
In vitro investigations of angiogenesis inhibition and tumor cell migration by an aqueous extract from Viscum album ssp. album Mali
|
Felenda, Jennifer E.
|
|
2019
|
61 |
S1 |
p. 1-2
|
artikel
|
| 32 |
Lectins, viscotoxins and low molecular weight active components of mistletoe plants
|
Pfüller, Uwe
|
|
2019
|
61 |
S1 |
p. 1-2
|
artikel
|
| 33 |
Lectures of invited speakers
|
|
|
2019
|
61 |
S1 |
p.
|
artikel
|
| 34 |
Long term results in osteosarcoma patients treated with Viscum album Fermentatum P versus Etoposide as maintenance therapy after second relapse
|
Longhi, Alessandra
|
|
2019
|
61 |
S1 |
p. 10-11
|
artikel
|
| 35 |
Long-term survival of a patient with advanced esophageal cancer under adjunct treatment with Viscum album extracts – A case report
|
Werthmann, Paul G
|
|
2019
|
61 |
S1 |
p. 8-9
|
artikel
|
| 36 |
Long-term survival of a patient with relapsing triple-negative breast cancer stage IIB under surgical treatment and Viscum album extracts – A case report
|
Werthmann, Paul Georg
|
|
2019
|
61 |
S1 |
p. 9
|
artikel
|
| 37 |
Metabolic profiling as a tool for differentiating Viscum album ssp. album plants growing on various host trees
|
Jäger, Tim
|
|
2019
|
61 |
S1 |
p. 1-2
|
artikel
|
| 38 |
Mistletoe lectin I reduces glioma cell motility by changing mainly the expression of genes associated to TGF-β signaling
|
Schötterl, Sonja
|
|
2019
|
61 |
S1 |
p. 3-4
|
artikel
|
| 39 |
Mistletoe therapy in primary and recurrent inoperable pancreatic cancer. A phase III prospective, randomized, double-blinded, multicenter, parallel group, placebo-controlled clinical trial on overall survival and health-related quality of life (MISTRAL)
|
Wode, Kathrin
|
|
2019
|
61 |
S1 |
p. 2-3
|
artikel
|
| 40 |
Mitotic effects of barks and inflorescences extracts of mistletoe Phoradendron mucronatum (DC.) Krug & Urb.
|
Rieder, Arno
|
|
2019
|
61 |
S1 |
p. 4-5
|
artikel
|
| 41 |
On-site integrative oncology: The Bochum/Hattinger model
|
Beer, André-Michael
|
|
2019
|
61 |
S1 |
p. 5-6
|
artikel
|
| 42 |
Overall survival after transcatheter hepatic mistletoe therapy of patients with hepatocellular carcinoma
|
Galun, Daniel
|
|
2019
|
61 |
S1 |
p. 6
|
artikel
|
| 43 |
Overview of viscumTT
|
Delebinski, Catharina
|
|
2019
|
61 |
S1 |
p. 5
|
artikel
|
| 44 |
Pain and use of analgesics in a randomized study of metastasized or locally advanced pancreatic carcinoma (MAPAC)
|
Reif, Marcus
|
|
2019
|
61 |
S1 |
p. 11
|
artikel
|
| 45 |
Pharmacoeconomics of anthroposophical mistletoe therapy – A status report
|
Reif, Marcus
|
|
2019
|
61 |
S1 |
p. 3
|
artikel
|
| 46 |
Poster presentations of the biology, pharmacy, immunology section
|
|
|
2019
|
61 |
S1 |
p.
|
artikel
|
| 47 |
Poster presentations section clinical practice and clinical research
|
|
|
2019
|
61 |
S1 |
p.
|
artikel
|
| 48 |
Potential clinical applications of the eastern Nigerian mistletoes: Evidences from two decades of investigations (1999-2019)
|
Omeje, E.O.
|
|
2019
|
61 |
S1 |
p. 3-4
|
artikel
|
| 49 |
Preclinical investigation of interaction of mistletoe extract (Viscum album L.) with radio- and chemotherapy in pediatric tumor cell lines
|
Menke, Katrin
|
|
2019
|
61 |
S1 |
p. 4
|
artikel
|
| 50 |
Preclinical studies on the significance of mistletoe preparations in the therapy of urological tumors
|
Jüngel, Eva
|
|
2019
|
61 |
S1 |
p. 4-5
|
artikel
|
| 51 |
Prolonged overall survival in patients with metastasized non-small cell lung carcinoma after combined treatment of chemotherapy and Viscum album L. versus chemotherapy alone, a cancer registry analysis
|
Matthes, Burkhard
|
|
2019
|
61 |
S1 |
p. 7-8
|
artikel
|
| 52 |
Psycho-oncological care in lung cancer: Are there site-specific features?
|
Grah, Christian
|
|
2019
|
61 |
S1 |
p. 4-5
|
artikel
|
| 53 |
Psycho-oncology today: The same approach for all patients? Or an organ-specific approach?
|
Matthes, Harald
|
|
2019
|
61 |
S1 |
p. 4
|
artikel
|
| 54 |
Psychosocial, cognitive, and physical impact of elaborate consultation and life review in female patients with non-metastasized breast cancer
|
Schad, Friedemann
|
|
2019
|
61 |
S1 |
p. 8
|
artikel
|
| 55 |
Quantitative analysis of receptor-mediated uptake and pro-apoptotic activity of mistletoe lectin-1 by high content imaging
|
de Matos, Maria B.C.
|
|
2019
|
61 |
S1 |
p. 3-4
|
artikel
|
| 56 |
Quantity and quality of triterpene acids of Viscum album L. on two different host species from Hyrcanian forests of Iran, Parrotia persica C.A. Mey. and Carpinus betulus L.
|
Fattahi, Farnoosh
|
|
2019
|
61 |
S1 |
p. 1
|
artikel
|
| 57 |
Reviews: Status of mistletoe therapy for breast and lung cancer
|
Matthes, Harald
|
|
2019
|
61 |
S1 |
p. 3-4
|
artikel
|
| 58 |
Selective inactivation of the B-subunit of mistletoe lectins and other RIP-II-Type lectins in “green solvents” -ionic liquids
|
Pfüller, Uwe
|
|
2019
|
61 |
S1 |
p. 4
|
artikel
|
| 59 |
Short lectures abstracts
|
|
|
2019
|
61 |
S1 |
p.
|
artikel
|
| 60 |
Sources of integrative medicine
|
Meyer, Frank
|
|
2019
|
61 |
S1 |
p. 5
|
artikel
|
| 61 |
Special features of cellular respiration in Viscum album
|
Schröder, Lucie
|
|
2019
|
61 |
S1 |
p. 1
|
artikel
|
| 62 |
Supportive mistletoe therapy in a patient with metastasized neuroblastoma
|
Kästner, Jens
|
|
2019
|
61 |
S1 |
p. 5-6
|
artikel
|
| 63 |
Symptoms of intracranial pressure during mistletoe extract administration
|
Tröger, Wilfried
|
|
2019
|
61 |
S1 |
p. 7
|
artikel
|
| 64 |
The effects of willow mistletoe preparations on human tumor cell lines in vitro
|
Felenda, Jennifer E.
|
|
2019
|
61 |
S1 |
p. 2-3
|
artikel
|
| 65 |
The therapeutic potential of Viscum album L. miRNA
|
Xie, Wenyan
|
|
2019
|
61 |
S1 |
p. 6-7
|
artikel
|
| 66 |
Three cases of remission of actinic keratosis, basal-cell carcinoma and squamous-cell carcinoma respectively by topical therapy with “Viscum album, Resina 10%, Unguentum”
|
Schläpfer, Dorothea
|
|
2019
|
61 |
S1 |
p. 8
|
artikel
|
| 67 |
Treatment of breast cancer patients with mistletoe extracts of various host trees: A descriptive database study
|
Rüdisüli, Anna
|
|
2019
|
61 |
S1 |
p. 2
|
artikel
|
| 68 |
Viscum album and a concomitant integrative medical therapy in a patient suffering from primary Raynaud syndrome and primary breast cancer – A 10-year follow-up case report
|
Pranga, Danilo
|
|
2019
|
61 |
S1 |
p. 5
|
artikel
|
| 69 |
Viscum album and immunotherapy
|
Weissenstein, Ulrike
|
|
2019
|
61 |
S1 |
p. 6
|
artikel
|
| 70 |
Viscum album induces Systemic Inflammatory Response Syndrome (SIRS) by intravenous application – conditioning numeric cellular and humoral immune stimulation and clinical efficacy. A prospective observational study in advanced cancer patients
|
Kuehn, Juergen J.
|
|
2019
|
61 |
S1 |
p. 9-10
|
artikel
|
| 71 |
Viscum album L. therapy effects in the context of the ACCEPT program – Companion-Study of quality of life and therapy adherence during multimodal therapy for lung cancer
|
Grah, Christian
|
|
2019
|
61 |
S1 |
p. 1
|
artikel
|
Tijdschrift beschrijving